Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review

During the course of lung cancer progression, bone metastases occur in about 40% of patients. Common complications associated with bone metastases in lung cancer patients include musculoskeletal pain, pathologic fractures, spinal cord compression, and hypercalcemia. We discuss the efficacy of bone-m...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Seminars in oncology 2023-06, Vol.50 (3-5), p.105-112
Hauptverfasser:	Kim, Jinyoung, Jeong, Chaiho, Lee, Jeongmin, Ha, Jeonghoon, Baek, Ki-Hyun, Kim, Seohyun, An, Tai Joon, Park, Chan Kwon, Yoon, Hyoung Kyu, Lim, Jeong Uk
Format:	Artikel
Sprache:	eng
Schlagworte:	Bone density conservation agents Lung cancer Metastases Osteoporosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!